3 Aug 2021 14:09
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 02 August 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
10,242,133 | 4.06% | 314,657 | 0.12% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
208,932 | 0.08% | 6,712,467 | 2.66% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
10,451,065 | 4.15% | 7,027,124 | 2.79% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1,121 | 10.7794 GBP |
| Purchase | 3,575 | 10.7714 GBP |
| Purchase | 9,220 | 10.7728 GBP |
| Purchase | 9,979 | 10.7723 GBP |
| Purchase | 20,239 | 10.7785 GBP |
| Purchase | 39,185 | 10.7707 GBP |
| Purchase | 40,998 | 10.7800 GBP |
| Purchase | 3,502,535 | 10.7700 GBP |
| Sale | 665 | 10.7700 GBP |
| Sale | 2,445 | 10.7682 GBP |
| Sale | 2,999 | 10.7712 GBP |
| Sale | 3,475 | 10.7775 GBP |
| Sale | 13,813 | 10.7744 GBP |
| Sale | 18,669 | 10.7805 GBP |
| Sale | 23,292 | 10.7800 GBP |
| Sale | 25,410 | 10.7710 GBP |
| Sale | 54,827 | 10.7750 GBP |
| Sale | 226,771 | 10.7732 GBP |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
|
| unit | |
| SWAP | Long | 55 | 10.7690 GBP |
| SWAP | Long | 1,578 | 10.7485 GBP |
| CFD | Long | 2,445 | 10.7682 GBP |
| CFD | Long | 3,475 | 10.7775 GBP |
| SWAP | Long | 7,705 | 10.7700 GBP |
| SWAP | Long | 8,128 | 10.7794 GBP |
| SWAP | Long | 12,072 | 10.7800 GBP |
| CFD | Long | 17,717 | 10.7675 GBP |
| SWAP | Short | 2,514 | 10.7794 GBP |
| SWAP | Short | 12,306 | 10.7735 GBP |
| SWAP | Short | 24,505 | 10.7800 GBP |
| CFD | Short | 65,748 | 10.7708 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 3 Aug 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20210803005700/en/
Copyright Business Wire 2021